[ORGANIZATION]

GLP-1 drugs

Featured in 2 tracked stories · first seen about 2 months ago

Situations

[ACTIVE] [HEALTH] [US] [BR] [DK]

GLP-1 obesity drug rollout and market expansion

105 clusters · 510 sources · last updated about 18 hours ago

Latest: Novo Nordisk reports pediatric obesity trial success amid market pressure

Novo Nordisk continues to expand its GLP-1 market presence, maintaining approximately a 43% global market share for obesity and diabetes treatments despite competition from Eli Lilly. The oral Wegovy pill remains a prima

[ACTIVE] [HEALTH] [US] [IN] [GB]

PMOS Renaming – Heart, Fertility & Mental Health

25 clusters · 133 sources · last updated 7 days ago

Latest: Medical experts rename PCOS to Polyendocrine Metabolic Ovarian Syndrome

Following the May 2026 international consensus renaming polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome (PMOS), new research and clinical developments have emerged regarding its management and risks